WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

Search

Hims & Hers Health Inc

Închisă

SectorConsumator defensiv

31.15 0.48

Rezumat

Modificarea prețului

24h

Curent

Minim

28.94

Maxim

31.21

Indicatori cheie

By Trading Economics

Venit

-50M

26M

Vânzări

80M

481M

P/E

Medie Sector

54.722

44.466

EPS

0.227

Marjă de profit

5.409

Angajați

1,637

EBITDA

-8.2M

19M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+49.76% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-4.7B

6.5B

Deschiderea anterioară

30.67

Închiderea anterioară

31.15

Sentimentul știrilor

By Acuity

18%

82%

9 / 152 Clasament în Consumer defensive

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Hims & Hers Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 apr. 2025, 23:15 UTC

Principalele dinamici ale pieței

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 feb. 2025, 15:33 UTC

Principalele dinamici ale pieței

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

18 nov. 2024, 19:07 UTC

Principalele dinamici ale pieței

Hims & Hers Stock Climbs After Former Regulator Autor Joins Board

14 oct. 2024, 15:02 UTC

Principalele dinamici ale pieței

Hims & Hers Health Shares Jump After FDA Set to Reconsider Limits on Knockoff Weight-Loss Drugs

3 oct. 2024, 11:28 UTC

Principalele dinamici ale pieței

Hims & Hers Health Shares Fall After FDA Removes Eli Lilly Obesity Drugs From Shortage List

2 apr. 2025, 16:53 UTC

Top știri

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mar. 2025, 15:54 UTC

Top știri

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 feb. 2025, 23:20 UTC

Câștiguri

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

10 feb. 2025, 12:00 UTC

Top știri

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business -- Heard on the Street -- WSJ

19 dec. 2024, 17:16 UTC

Top știri

FDA Says Shortage of Eli Lilly's Zepbound is Over, But Gives Compounders a Grace Period -- Barrons.com

19 dec. 2024, 15:14 UTC

Top știri

Eli Lilly's Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

19 dec. 2024, 15:02 UTC

Top știri

The Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

16 dec. 2024, 13:47 UTC

Top știri

The Weight-Loss Drug Market Is Heading for a Reckoning This Week -- Barrons.com

16 dec. 2024, 07:00 UTC

Top știri

The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect. -- Barrons.com

3 oct. 2024, 14:45 UTC

Top știri

Eli Lilly's Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 13:12 UTC

Top știri

Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 11:45 UTC

Top știri

Update: Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 10:14 UTC

Top știri

Update: Eli Lilly's Weight-Loss Drugs No Longer In Shortage. It's Bad News for These Stocks. -- Barrons.com

2 aug. 2024, 17:52 UTC

Achiziții, Fuziuni, Preluări

Hims & Hers Plan to Sell Knockoff Weight Loss Drug Looking Shaky -- Barrons.com

26 iun. 2024, 11:00 UTC

Top știri
Achiziții, Fuziuni, Preluări

The War Over Cheaper Ozempic Won't End Well for Some Investors -- Heard on the Street -- WSJ

24 mai 2024, 20:37 UTC

Câștiguri

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week -- WSJ

Comparație

Modificare preț

Hims & Hers Health Inc Așteptări

Obiectiv de preț

By TipRanks

49.76% sus

Prognoză pe 12 luni

Medie 46.5 USD  49.76%

Maxim 85 USD

Minim 21 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHims & Hers Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

13 ratings

5

Cumpărare

6

Păstrare

2

Vânzare

Scor tehnic

By Trading Central

31.0237 / 31.88Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

9 / 152 Clasament în Consumator defensiv

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.